| |
| |
|
| Insider
Information: |
Middleton Fred A |
| Relationship: |
|
| City: |
San Mateo |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
6 |
|
| Direct
Shares |
593,164 |
|
|
Indirect Shares
|
7,544,680 |
|
|
| Direct
Value |
$3,059,061 |
|
|
|
Indirect Value
|
$6,091,574 |
|
|
| Total
Shares |
8,137,844 |
|
|
| Total
Value |
$9,150,635 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
9
|
0
|
|
Stock
price went up :
|
4
|
0
|
| Stock
price went down : |
5
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
 2.9%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Stereotaxis Inc |
STXS |
Director |
2018-03-02 |
303,528 |
2018-03-02 |
1,325,167 |
Premium* |
|
|
Mmrglobal Inc |
MMRF |
Director |
2008-12-09 |
0 |
2006-03-07 |
2,773,091 |
Premium* |
|
|
Pacira Pharmaceuticals, Inc. |
PCRX |
Director |
2013-06-24 |
70,399 |
2013-06-24 |
0 |
Premium* |
|
|
Endocyte Inc |
ECYT |
Director |
2018-12-21 |
0 |
2018-12-21 |
0 |
Premium* |
|
|
Chimerix Inc |
CMRX |
Director |
2023-11-17 |
207,523 |
2023-11-17 |
3,407,954 |
Premium* |
|
|
Calcimedica Ord Shs |
CALC |
|
2024-01-23 |
11,714 |
2024-01-23 |
38,468 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
133 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 5 of 6
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ECYT |
Endocyte Inc |
Director |
– • – |
2016-05-05 |
4 |
A |
$0.00 |
$0 |
D/D |
2,250 |
203,249 |
0 |
- |
|
| CMRX |
Chimerix Inc |
Director |
– • – |
2021-06-28 |
4 |
B |
$7.83 |
$54,419 |
D/D |
6,950 |
207,523 |
2.39 |
% |
|
| STXS |
Stereotaxis Inc |
Director |
– • • |
2008-06-13 |
4 |
B |
$5.07 |
$60,273 |
D/D |
11,800 |
209,586 |
3.92 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • • |
2008-11-17 |
4 |
B |
$2.69 |
$32,028 |
D/D |
11,915 |
221,493 |
3.92 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • • |
2008-11-18 |
4 |
B |
$3.00 |
$879 |
D/D |
293 |
221,786 |
3.84 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • • |
2009-05-22 |
4 |
B |
$3.45 |
$26,931 |
D/D |
7,806 |
229,600 |
3.92 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • • |
2009-05-26 |
4 |
B |
$3.44 |
$68,814 |
D/D |
19,986 |
249,586 |
3.92 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • • |
2009-08-31 |
4 |
B |
$3.54 |
$17,700 |
D/D |
5,000 |
254,586 |
3.92 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2011-02-04 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
279,229 |
|
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • • |
2010-08-18 |
4 |
B |
$3.25 |
$84,500 |
D/D |
26,000 |
280,586 |
3.92 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2012-05-10 |
4 |
B |
$0.00 |
$0 |
I/I |
6,506,181 |
281,178 |
2.02 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2011-05-25 |
4 |
A |
$0.00 |
$0 |
D/D |
7,200 |
287,786 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2011-06-14 |
4 |
B |
$3.00 |
$30,000 |
D/D |
10,000 |
297,786 |
2.39 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2018-03-02 |
4 |
OE |
$0.28 |
$43,077 |
D/D |
153,846 |
303,528 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2011-09-01 |
4 |
B |
$1.37 |
$23,453 |
D/D |
17,119 |
314,905 |
2.39 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2011-09-15 |
4 |
B |
$1.38 |
$6,693 |
D/D |
4,850 |
319,755 |
2.39 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • – |
2013-03-19 |
4 |
AS |
$26.95 |
$2,306,831 |
D/D |
(84,589) |
416,083 |
0 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • • |
2013-03-11 |
4/A |
S |
$27.86 |
$9,721,775 |
D/D |
(348,951) |
559,453 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2011-02-07 |
4 |
B |
$6.00 |
$4,999,998 |
I/I |
833,333 |
785,417 |
2.1 |
- |
|
| PCRX |
Pacira Pharmaceuticals, I... |
Director |
– • • |
2013-01-24 |
4/A |
S |
$18.93 |
$9,465,000 |
D/D |
(500,000) |
882,562 |
0 |
- |
|
| ECYT |
Endocyte Inc |
Director |
– • – |
2018-02-28 |
4 |
A |
$4.20 |
$2,100,000 |
I/I |
500,000 |
904,465 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2015-06-15 |
4 |
S |
$1.57 |
$40,920 |
I/I |
(26,064) |
1,107,189 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2015-06-12 |
4 |
S |
$1.60 |
$1,786 |
I/I |
(1,116) |
1,133,253 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2015-06-11 |
4 |
S |
$1.61 |
$18,842 |
I/I |
(11,703) |
1,134,369 |
0 |
- |
|
| STXS |
Stereotaxis Inc |
Director |
– • – |
2015-06-10 |
4 |
S |
$1.60 |
$5,526 |
I/I |
(3,454) |
1,146,072 |
0 |
- |
|
133 Records found
|
|
Page 5 of 6 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
